Gara Jalqabaatti › Burkitt Lymphoma › Maryland › Baltimore
Qorannoo klinikaalii Burkitt Lymphoma Baltimore, MD keessatti
Qorannoo 8 Burkitt Lymphoma f Baltimore fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Namoota walitti qabaa jiraSadarkaa 2
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Namoota walitti qabaa jiraSadarkaa 3
- University of Maryland/Greenebaum Cancer Center, Baltimore
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Namoota walitti qabaa jiraSadarkaa 2
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Namoota walitti qabaa jiraSadarkaa 3
- Johns Hopkins Asthma & Allergy Center, Baltimore
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Namoota walitti qabaa jiraSadarkaa 1
- University of Maryland, Baltimore
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Namoota walitti qabaa jiraSadarkaa 2
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Namoota walitti qabaa jiraSadarkaa 3
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
Namoota walitti qabaa jiraSadarkaa 1
- University of Maryland, Baltimore
Qorannoo Burkitt Lymphoma magaalota biroo keessatti
- Houston, TXQorannoo 21
- Milwaukee, WIQorannoo 16
- Philadelphia, PAQorannoo 16
- New York City, NYQorannoo 14
- Chicago, ILQorannoo 14
- Cincinnati, OHQorannoo 12
- Atlanta, GAQorannoo 12
- Seattle, WAQorannoo 11
- Boston, MAQorannoo 10
- Durham, NCQorannoo 10
- Los Angeles, CAQorannoo 10
- Kansas City, MOQorannoo 10
Qorannoo biroo Baltimore keessatti
- Kansara Qara'a Non-Small CellQorannoo 60
- Saree OljooQorannoo 47
- Kansarii ProstateQorannoo 43
- Dhibee QaraQorannoo 40
- Saree (Gosoota Hunda)Qorannoo 37
- Kansarii ColorectalQorannoo 31
- Kansarii PancreasQorannoo 31
- Kansara MetastatikiiQorannoo 28
- ObesityQorannoo 25
- Cufama OnneeQorannoo 24
- Dukkana BladderQorannoo 24
- StrokeQorannoo 22
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.